The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis

Author: van Dijk Marianne   Murphy Eoin   Morrell Ruth   Knapper Steven   O'Dwyer Michael   Samali Afshin   Szegezdi Eva  

Publisher: MDPI

E-ISSN: 2072-6694|3|1|1329-1350

ISSN: 2072-6694

Source: Cancers, Vol.3, Iss.1, 2011-03, pp. : 1329-1350

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content